Anxiogenic-like effects induced by hemopressin in rats

Pharmacology Biochemistry and Behavior

Volumn 129, Issue , 2015, Pages 7-13

  Fogaça, Manoela V ^a   Sonego, Andreza B ^a   Rioli, Vanessa ^b   Gozzo, Fabio C ^c   Dale, Camila S ^a   Ferro, Emer S ^a   Guimarães, Francisco S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Anxiety; Cannabinoid; CB1 receptors; Endocannabinoids; Hemopressin; TRPV1 receptors

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANXIOLYTIC AGENT; BRAIN EXTRACT; DIAZEPAM; HEMOPRESSIN; UNCLASSIFIED DRUG; 6-IODONORDIHYDROCAPSAICIN; ANILIDE; CAPSAICIN; CINNAMIC ACID DERIVATIVE; HEMOGLOBIN; N-(3-METHOXYPHENYL)-4-CHLOROCINNAMANILIDE; PEPTIDE FRAGMENT; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; MALE; MASS SPECTROMETRY; MICROINJECTION; NONHUMAN; RAT; STEREOTAXIC SURGERY; TRANQUILIZING ACTIVITY; ANALOGS AND DERIVATIVES; ANIMAL; ANXIETY; BRAIN; CHEMICALLY INDUCED; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MAZE TEST; METABOLISM; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ANILIDES; ANIMALS; ANXIETY; BRAIN; CAPSAICIN; CINNAMATES; HEMOGLOBINS; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; PEPTIDE FRAGMENTS; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR;

EID: 84917690581     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.11.013     Document Type: Article

References (50)

1. D.C. Aguiar, A.L. Terzian, F.S. Guimaraes, and F.A. Moreira Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats Psychopharmacology (Berl) 205 2 2009 217 225
2. D.C. Aguiar, F.A. Moreira, A.L. Terzian, M.V. Fogaça, S.F. Lisboa, and C.T. Wotjak Modulation of defensive behavior by Transient Receptor Potential Vanilloid Type-1 (TRPV1) channels Neurosci Biobehav Rev 2014 10.1016/j.neubiorev.2014.03.026 (pii: S0149-7634(14)00083-9)
3. M. Bauer, A. Chicca, M. Tamborrini, D. Eisen, R. Lerner, and B. Lutz Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors J Biol Chem 287 44 2012 36944 36967
4. P.A. Blais, J. Côté, J. Morin, A. Larouche, G. Gendron, and A. Fortier Hypotensive effects of hemopressin and bradykinin in rabbits, rats and mice. A comparative study Peptides 26 8 2005 1317 1322
5. M.S. Brownfield, I.A. Reid, D. Ganten, and W.F. Ganong Differential distribution of immunoreactive angiotensin and angiotensin-converting enzyme in rat brain Neuroscience 7 7 1982 1759 1769
6. A.C. Campos, and F.S. Guimarães Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats Psychopharmacology (Berl) 199 2 2008 223 230
7. A.C. Campos, and F.S. Guimarães Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids Prog Neuropsychopharmacol Biol Psychiatry 33 8 2009 1517 1521
8. P.C. Casarotto, A.L. Terzian, D.C. Aguiar, H. Zangrossi, F.S. Guimarães, and C.T. Wotjak Opposing roles for cannabinoid receptor type-1 (CB) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats Neuropsychopharmacology 37 2 2012 478 486
9. C. Chevillard, and J.M. Saavedra Distribution of angiotensin-converting enzyme activity in specific areas of the rat brain stem J Neurochem 38 1 1982 281 284
10. R. Christensen, P.K. Kristensen, E.M. Bartels, H. Bliddal, and A. Astrup Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials Lancet 370 9600 2007 1706 1713
11. M.A. Cicilini, H. Caldo, J.D. Berti, and A.C. Camargo Rabbit tissue peptidases that hydrolyse the peptide hormone bradykinin. Differences in enzymic properties and concentration in rabbit tissues Biochem J 163 3 1977 433 439
12. C.S. Dale, L. Pagano Rde, and V. Rioli Hemopressin: a novel bioactive peptide derived from the alpha1-chain of hemoglobin Mem Inst Oswaldo Cruz 100 Suppl. 1 2005 105 106
13. C.S. Dale, L. Pagano Rde, V. Rioli, S. Hyslop, R. Giorgi, and E.S. Ferro Antinociceptive action of hemopressin in experimental hyperalgesia Peptides 26 3 2005 431 436
14. V. Di Marzo, T. Bisogno, and L. De Petrocellis Anandamide: some like it hot Trends Pharmacol Sci 22 7 2001 346 349
15. G.T. Dodd, G. Mancini, B. Lutz, and S.M. Luckman The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice J Neurosci 30 21 2010 7369 7376
16. G.T. Dodd, A.A. Worth, D.J. Hodkinson, R.K. Srivastava, B. Lutz, and S.R. Williams Central functional response to the novel peptide cannabinoid, hemopressin Neuropharmacology 71 2013 27 36
17. M.V. Fogaça, D.C. Aguiar, F.A. Moreira, and F.S. Guimarães The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior Neuropharmacology 63 2 2012 202 210
18. M.V. Fogaça, S.F. Lisboa, D.C. Aguiar, F.A. Moreira, F.V. Gomes, and P.C. Casarotto Fine-tuning of defensive behaviors in the dorsal periaqueductal gray by atypical neurotransmitters Braz J Med Biol Res 45 4 2012 357 365
19. M.V. Fogaça, F.V. Gomes, F.A. Moreira, F.S. Guimarães, and D.C. Aguiar Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats Psychopharmacology (Berl) 226 3 2013 579 587
20. J.D. Fontenele-Neto, E.E. Massarelli, P.A. Gurgel Garrido, A. Beaudet, and E.S. Ferro Comparative fine structural distribution of endopeptidase 24.15 (EC3.4.24.15) and 24.16 (EC3.4.24.16) in rat brain J Comp Neurol 438 4 2001 399 410
21. I. Gomes, J.S. Grushko, U. Golebiewska, S. Hoogendoorn, A. Gupta, and A.S. Heimann Novel endogenous peptide agonists of cannabinoid receptors FASEB J 23 9 2009 3020 3029
22. I. Gomes, C.S. Dale, K. Casten, M.A. Geigner, F.C. Gozzo, and E.S. Ferro Hemoglobin-derived peptides as novel type of bioactive signaling molecules AAPS J 12 4 2010 658 669
23. F.S. Guimarães, T.M. Chiaretti, F.G. Graeff, and A.W. Zuardi Antianxiety effect of cannabidiol in the elevated plus-maze Psychopharmacology (Berl) 100 4 1990 558 559
24. A. Hama, and J. Sagen Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception Pharmacol Biochem Behav 100 2 2011 340 346
25. A.S. Heimann, I. Gomes, C.S. Dale, R.L. Pagano, A. Gupta, and L.L. de Souza Hemopressin is an inverse agonist of CB1 cannabinoid receptors Proc Natl Acad Sci U S A 104 51 2007 20588 20593
26. J. Lazary, G. Juhasz, L. Hunyady, and G. Bagdy Personalized medicine can pave the way for the safe use of CB receptor antagonists Trends Pharmacol Sci 32 5 2011 270 280
27. X.H. Li, N. Li, Z.L. Wang, J.X. Pan, Z.L. Han, and X.M. Chang The hypotensive effect of intrathecally injected (m)VD-hemopressin(α) in urethane-anesthetized rats Peptides 56 2014 45 51
28. H. Lippton, B. Lin, B. Gumusel, N. Witriol, A. Wasserman, and M. Knight Hemopressin, a hemoglobin fragment, dilates the rat systemic vascular bed through release of nitric oxide Peptides 27 9 2006 2284 2288
29. E.E. Massarelli, C.A. Casatti, A. Kato, A.C. Camargo, J.A. Bauer, and M.J. Glucksman Differential subcellular distribution of neurolysin (EC 3.4.24.16) and thimet oligopeptidase (EC 3.4.24.15) in the rat brain Brain Res 851 1-2 1999 261 265
30. F.A. Moreira, and J.A. Crippa The psychiatric side-effects of rimonabant Rev Bras Psiquiatr 31 2 2009 145 153
31. F.A. Moreira, and B. Lutz The endocannabinoid system: emotion, learning and addiction Addict Biol 13 2 2008 196 212
32. F.A. Moreira, M. Grieb, and B. Lutz Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression Best Pract Res Clin Endocrinol Metab 23 1 2009 133 144
33. A. Musella, V. De Chiara, S. Rossi, C. Prosperetti, G. Bernardi, and M. Maccarrone TRPV1 channels facilitate glutamate transmission in the striatum Mol Cell Neurosci 40 1 2009 89 97
34. R.S. Padwal, and S.R. Majumdar Drug treatments for obesity: orlistat, sibutramine, and rimonabant Lancet 369 9555 2007 71 77
35. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 2005 Academic Press New York
36. T.J. Price, A. Patwardhan, A.N. Akopian, K.M. Hargreaves, and C.M. Flores Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-opamine and arachidonyl-2-chloroethylamide Br J Pharmacol 141 7 2004 1118 1130
37. L.B. Resstel, S.R. Joca, F.A. Moreira, F.M. Corrêa, and F.S. Guimarães Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats Behav Brain Res 172 2 2006 294 298
38. V. Rioli, F.C. Gozzo, A.S. Heimann, A. Linardi, J.E. Krieger, and C.S. Shida Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme J Biol Chem 278 10 2003 8547 8555
39. R.A. Ross Anandamide and vanilloid TRPV1 receptors Br J Pharmacol 140 5 2003 790 801
40. T. Rubino, N. Realini, C. Castiglioni, C. Guidali, D. Viganó, and E. Marras Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex Cereb Cortex 18 6 2008 1292 1301
41. D. Rucker, R. Padwal, S.K. Li, C. Curioni, and D.C. Lau Long term pharmacotherapy for obesity and overweight: updated meta-analysis BMJ 335 7631 2007 1194 1199
42. M. Scrima, S. Di Marino, M. Grimaldi, A. Mastrogiacomo, E. Novellino, and M. Bifulco Binding of the hemopressin peptide to the cannabinoid CB1 receptor: structural insights Biochemistry 49 49 2010 10449 10457
43. D. Smart, M.J. Gunthorpe, J.C. Jerman, S. Nasir, J. Gray, and A.I. Muir The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) Br J Pharmacol 129 2 2000 227 233
44. K. Starowicz, S. Maione, L. Cristino, E. Palazzo, I. Marabese, and F. Rossi Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways J Neurosci 27 50 2007 13739 13749
45. A.L. Terzian, D.C. Aguiar, F.S. Guimarães, and F.A. Moreira Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray Eur Neuropsychopharmacol 19 3 2009 188 195
46. E.F. Toniolo, E.T. Maique, W.A. Ferreira Jr.; A.S. Heimann, E.S. Ferro, and D.L. Ramos-Ortolaza Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats Peptides 56C 2014 125 131
47. M. Van Der Stelt, and V. Di Marzo Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels Eur J Biochem 271 10 2004 1827 1834
48. M.P. Viveros, E.M. Marco, and S.E. File Endocannabinoid system and stress and anxiety responses Pharmacol Biochem Behav 81 2 2005 331 342
49. C. Zschenderlein, C. Gebhardt, O. von Bohlen Und Halbach, C. Kulisch, and D. Albrecht Capsaicin-induced changes in LTP in the lateral amygdala are mediated by TRPV1 PLoS One 6 1 2011 e16116
50. P.M. Zygmunt, J. Petersson, D.A. Andersson, H. Chuang, M. Sørgård, and V. Di Marzo Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 6743 1999 452 457